Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.07% |
| 2 | Technology | 14.35% |
| 3 | Financials | 11.23% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Real Estate | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IEC
2276
DELISTED
IEC Electronics Corp.
IEC
| $2.17M | ﹤0.01% |
345,983
-108,917
| -24% | -$721K |
|
2277
Darling Ingredients
DAR
$10.6B
| $2.17M | ﹤0.01% |
109,100
-154,800
| -59% | -$3.17M |
|
2278
Maximus
MMS
$2.9B
| $2.17M | ﹤0.01% |
29,900
-415,200
| -93% | -$30.1M |
|
|
DOVA
2279
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $2.17M | ﹤0.01% |
153,700
+127,900
| +496% | +$1.22M |
|
2280
Vermilion Energy
VET
$1.74B
| $2.16M | ﹤0.01% |
99,600
-80,100
| -45% | -$1.87M |
|
2281
iShares Biotechnology ETF
IBB
$9.66B
| $2.16M | ﹤0.01% |
19,800
+9,500
| +92% | +$1.01M |
|
2282
Vanguard World Funds Extended Duration ETF
EDV
$3.46B
| $2.16M | ﹤0.01% |
17,000
+5,800
| +52% | +$698K |
|
2283
Innovative Solutions & Support
ISSC
$420M
| $2.16M | ﹤0.01% |
422,776
+18,989
| +5% | +$76.3K |
|
2284
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.7B
| $2.15M | ﹤0.01% |
+17,300
| New | +$2.08M |
|
|
SEAC
2285
DELISTED
Seachange International Inc
SEAC
| $2.15M | ﹤0.01% |
75,091
+873
| +1% | +$23.3K |
|
2286
Alico
ALCO
$304M
| $2.15M | ﹤0.01% |
70,707
-12,884
| -15% | -$356K |
|
2287
Compugen
CGEN
$225M
| $2.14M | ﹤0.01% |
557,800
+95,500
| +21% | +$338K |
|
|
MN
2288
DELISTED
MANNING & NAPIER, INC.
MN
| $2.13M | ﹤0.01% |
1,217,699
+13,200
| +1% | +$26.8K |
|
2289
Manitowoc
MTW
$757M
| $2.13M | ﹤0.01% |
119,549
-168,600
| -59% | -$2.8M |
|
|
FINV
2290
FinVolution Group
FINV
$1.05B
| $2.12M | ﹤0.01% |
487,500
+466,700
| +2,244% | +$2.3M |
|
|
LHCG
2291
DELISTED
LHC Group LLC
LHCG
| $2.12M | ﹤0.01% |
17,727
-8,443
| -32% | -$952K |
|
|
TUES
2292
DELISTED
Tuesday Morning Corp
TUES
| $2.12M | ﹤0.01% |
1,254,587
+380,811
| +44% | +$693K |
|
|
PETX
2293
DELISTED
Aratana Therapeutics, Inc.
PETX
| $2.11M | ﹤0.01% |
408,889
+218,100
| +114% | +$980K |
|
|
SCHR
2294
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.4B
| $2.11M | ﹤0.01% |
76,742
-20,400
| -21% | -$551K |
|
|
BBQ
2295
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $2.11M | ﹤0.01% |
478,199
-4,168
| -0.9% | -$19.9K |
|
2296
Kennametal
KMT
$2.35B
| $2.1M | ﹤0.01% |
56,858
-328,600
| -85% | -$11.9M |
|
|
CSTR
2297
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $2.1M | ﹤0.01% |
138,572
+32,300
| +30% | +$495K |
|
2298
Dana Inc
DAN
$3.35B
| $2.1M | ﹤0.01% |
105,200
-960,300
| -90% | -$17.1M |
|
2299
Citizens
CIA
$203M
| $2.09M | ﹤0.01% |
286,800
+92,500
| +48% | +$634K |
|
2300
Genworth Financial
GNW
$3.82B
| $2.09M | ﹤0.01% |
564,400
-144,600
| -20% | -$512K |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.